Visitors at this year’s HIE trade show will be introduced to Chr. Hansen’s newest probiotic solutions and phytonutrients for the F&B and dietary supplements industries.
“We are looking forward to showcasing our newest probiotic strain, Lactobacillus fermentum PCC® which is clinically documented to benefit immune health, particularly in athletes. We are proud that PCC® has been nominated for the “Health Ingredients Excellence Award” within the Sports Performance category”, says Charlotte Beyerholm, Marketing Manager, Human Health & Nutrition.
Chr. Hansen will bring other innovative probiotic dietary supplements products to HIE, too, e.g. the probiotic strain Lactobacillus F19® and the newly launched anti-constipation supplement containing efficacious probiotics and beneficial fibers.
Healthy drinking yogurts
In the dairy ingredients category, Chr. Hansen will be displaying its first range of YoFlex® and probiotic nu-trish® cultures specifically developed for drinking yogurt. “We will be sampling different drinking yogurts and visitors will have the chance to taste the incredible difference in smoothness and creaminess between existing cultures and the new ones,” says Sarita Bairoliya, Global Marketing Manager, Probiotics, Cultures & Enzymes.
“Consumers want the health benefit provided by our flagship probiotic strain BB-12®, but this must be in combination with good taste and texture. This is exactly what the new cultures ensure”, Bairoliya explains.
Innovative beverage concept
Finally, in the phytonutrient category Chr. Hansen will present its NutriPhy® range, an innovative natural color concept for beverages. For instance, visitors will be able to learn about the benefits of NutriPhy® Lingonberry, a powerful ingredient with documented health benefits.
Meet Chr. Hansen’s experts at our stand in Madrid – No R61 – and be inspired by our premium probiotic and natural color solutions.
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.